VEXAS Syndrome-A Review of Pathophysiology, Presentation, and Prognosis.
Koster MJ, Samec MJ, Warrington KJ.
J Clin Rheumatol. 2023 Sep 1;29(6):298-306. doi: 10.1097/RHU.0000000000001905. Epub 2022 Oct 17.
[VEXAS syndrome].
Zeeck M, Kötter I, Krusche M.
Z Rheumatol. 2022 Nov;81(9):782-786. doi: 10.1007/s00393-022-01169-6. Epub 2022 Feb 18.
Syndrome X.
[No authors listed]
Lancet. 1987 Nov 28;2(8570):1247-8.
Syndrome X.
Cheng TO.
N Z Med J. 1994 Apr 13;107(975):139.
Syndromic Craniosynostosis.
Sawh-Martinez R, Steinbacher DM.
Clin Plast Surg. 2019 Apr;46(2):141-155. doi: 10.1016/j.cps.2018.11.009.
Syndrome(s) X.
[No authors listed]
Lancet. 1991 Apr 13;337(8746):916-7.
Familial colorectal cancer syndrome X.
Lipkin SM, Afrasiabi K.
Semin Oncol. 2007 Oct;34(5):425-7. doi: 10.1053/j.seminoncol.2007.07.008.
Xiphoid process syndrome.
Teng ZY, Yang WX, Pu JT.
Am J Med Sci. 2024 Feb;367(2):e22. doi: 10.1016/j.amjms.2023.09.019. Epub 2023 Sep 16.
VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease.
Saad AJ, Patil MK, Cruz N, Lam CS, O'Brien C, Nambudiri VE.
Exp Dermatol. 2024 Mar;33(3):e15050. doi: 10.1111/exd.15050.
Loss-of-function variant in SPIN4 causes an X-linked overgrowth syndrome.
Lui JC, Wagner J, Zhou E, Dong L, Barnes KM, Jee YH, Baron J.
JCI Insight. 2023 May 8;8(9):e167074. doi: 10.1172/jci.insight.167074.
